From January 1, 2024 to March 31, 2024, the company has repurchased 2,966,000 shares, representing 0.2% for CNY 38.41 million. With this, the company has completed the repurchase of 7,023,100 shares, representing 0.48% for CNY 99.99 million under the buyback announced on November 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.75 CNY | +3.97% | +6.62% | +14.18% |
May. 02 | Huahai Pharmaceutical's Q1 Profit Jumps 57%, Income Up 21% | MT |
Apr. 29 | Zhejiang Huahai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.18% | 3.41B | |
+29.68% | 681B | |
+20.93% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.53% | 235B | |
+4.34% | 199B | |
-10.96% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- 600521 Stock
- News Zhejiang Huahai Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 14, 2023.